Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MAGEC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MYOF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ITSN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DKK3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TRIM2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NOLC1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARR3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NECAP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
STARD8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GM2A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IL5RA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C1QB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SGCG - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
STAT6 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HIVEP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MSX2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARFIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MTF2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NEDD9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EXOC3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on